Calidi Biotherapeutics Inc.
13F holders, Q1 2024 (March 31)31holders
$0.56avg. 13F price*
At the end of Q1 2024, 31 institutions reported holding Calidi Biotherapeutics Inc. in their 13F filings. The largest holders were Red Wave Investments LLC ($364K), Cable Car Capital, LP ($267K) and Meteora Capital, LLC ($141K).
- Company
- Calidi Biotherapeutics Inc.
- CUSIP
- 320703101
- Latest filing quarter
- Q2 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $251K |
| Exits | 3 | $200K |
Ownership 31 holders
| Red Wave Investments LLC | 0.14% | Add +1039.9% | 644,602 | $364K |
| Cable Car Capital, LP | 0.40% | Reduce -12.3% | 472,760 | $267K |
| Meteora Capital, LLC | 0.02% | Reduce -13.5% | 249,810 | $141K |
| Spectrum Asset Management, Inc. (NB/CA) | 0.04% | No change | 166,494 | $94K |
| Finepoint Capital LP | 0.02% | No change | 125,000 | $71K |
| Apollo Management Holdings, L.P. | 0.00% | New | 125,000 | $71K |
| Polar Asset Management Partners Inc. | 0.00% | No change | 125,000 | $65K |
| Geode Capital Management, LLC | 0.00% | Add +4.8% | 107,110 | $61K |
| Governors Lane LP | 0.01% | No change | 94,697 | $54K |
| Driehaus Capital Management LLC | 0.00% | No change | 94,697 | $54K |
| CPR Investments Inc. | 0.03% | New | 70,000 | $45K |
| Evermay Wealth Management LLC | 0.01% | New | 63,416 | $36K |
| Marshall Wace, LLP | 0.00% | New | 61,869 | $35K |
| Pegasus Partners Ltd. | 0.00% | Add +45.5% | 55,000 | $31K |
| Magnetar Financial LLC | 0.00% | No change | 63,132 | $31K |
| 683 Capital Management, LLC | 0.00% | New | 48,016 | $27K |
| Virtu Financial LLC | 0.00% | New | 42,062 | $24K |
| Morgan Stanley | 0.00% | No change | 19,187 | $11K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +1767900.0% | 17,680 | $10K |
| Vanguard Group Inc. | 0.00% | Add +20.0% | 14,939 | $8K |
| HRT Financial LP | 0.00% | Reduce -15.0% | 14,071 | $7K |
| Pure Financial Advisors, LLC | 0.00% | No change | 11,892 | $7K |
| RS Crum Inc. | 0.00% | New | 10,854 | $6K |
| Delta Investment Management, LLC | 0.00% | No change | 10,230 | $6K |
| Creative Planning | 0.00% | New | 10,000 | $6K |
| BlackRock Inc. | 0.00% | No change | 2,588 | $1K |
| Osaic Holdings, Inc. | 0.00% | New | 2,525 | $1K |
| Qube Research & Technologies Ltd | 0.00% | Reduce -78.2% | 599 | $338 |
| Wells Fargo & Company | 0.00% | Add +0.7% | 139 | $79 |
| PNC Financial Services Group, Inc. | 0.00% | No change | 100 | $57 |
| UBS Group AG | 0.00% | No change | 10 | $6 |
"% of holder's portfolio" is CALIDI BIOTHERAPEUTICS INC's weight in each manager's 13F, not the share of Calidi Biotherapeutics Inc. the manager owns.